Genpact Limited Stock Performance

G Stock  USD 40.39  2.69  7.14%   
The company retains a Market Volatility (i.e., Beta) of 1.25, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Genpact will likely underperform. At this point, Genpact Limited has a negative expected return of -0.12%. Please make sure to check out Genpact's downside variance, daily balance of power, and the relationship between the maximum drawdown and skewness , to decide if Genpact Limited performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Genpact Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more

Actual Historical Performance (%)

One Day Return
7.14
Five Day Return
(9.24)
Year To Date Return
(12.02)
Ten Year Return
61.5
All Time Return
141.13
Forward Dividend Yield
0.018
Payout Ratio
0.1858
Forward Dividend Rate
0.68
Dividend Date
2025-12-23
Ex Dividend Date
2025-12-09
1
Disposition of 26531 shares by Sameer Dewan of Genpact at 44.7 subject to Rule 16b-3
11/11/2025
2
Acquisition by Sameer Dewan of 56969 shares of Genpact subject to Rule 16b-3
12/02/2025
3
Genpact Assessing Valuation as HFS Names It a Horizon 3 Leader in Intelligent Supply Chain AI
12/09/2025
 
Genpact dividend paid on 23rd of December 2025
12/23/2025
5
Genpact Insiders Sold US14m Of Shares Suggesting Hesitancy
01/08/2026
6
Disposition of 12029 shares by Michael Weiner of Genpact at 48.24 subject to Rule 16b-3
01/09/2026
7
The Autonomous Enterprise Is Coming, And Genpact Research Finds 12 percent Are Leading The Way
01/13/2026
8
Genpact SVP Sameer Dewan Sells 15,088 Shares of Stock
01/14/2026
9
How Genpacts Agentic AI Research and Orchestration Strategy Will Impact Genpact Investors
01/16/2026
10
Genpact Named a Leader in Everest Groups Banking Operations PEAK Matrix Assessment 2025
01/22/2026
11
Head to Head Review Vertiv and Genpact
01/29/2026
12
Acquisition by Michael Weiner of 35396 shares of Genpact subject to Rule 16b-3
01/30/2026
13
Genpact Faces Pressure Following New Tech Release - GuruFocus
02/03/2026
14
Genpact to Release Quarterly Earnings on Thursday
02/04/2026
15
Why Are Genpact Shares Soaring Today
02/06/2026
Begin Period Cash Flow648.2 M
Total Cashflows From Investing Activities-495.5 M

Genpact Relative Risk vs. Return Landscape

If you would invest  4,411  in Genpact Limited on November 9, 2025 and sell it today you would lose (372.00) from holding Genpact Limited or give up 8.43% of portfolio value over 90 days. Genpact Limited is generating negative expected returns and assumes 2.1578% volatility on return distribution over the 90 days horizon. Put is differently, 19% of stocks are less volatile than Genpact, and over 99% of all traded equities are expected to make higher returns on investment over the next 90 days.
  Expected Return   
       Risk  
Taking into account the 90-day investment horizon Genpact is expected to under-perform the market. In addition to that, the company is 2.63 times more volatile than its market benchmark. It trades about -0.06 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Genpact Target Price Odds to finish over Current Price

The tendency of Genpact Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 40.39 90 days 40.39 
under 95
Based on a normal probability distribution, the odds of Genpact to move above the current price in 90 days from now is under 95 (This Genpact Limited probability density function shows the probability of Genpact Stock to fall within a particular range of prices over 90 days) .
Taking into account the 90-day investment horizon the stock has the beta coefficient of 1.25 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Genpact will likely underperform. Additionally Genpact Limited has an alpha of 0.0232, implying that it can generate a 0.0232 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Genpact Price Density   
       Price  

Predictive Modules for Genpact

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genpact Limited. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
38.2240.3842.54
Details
Intrinsic
Valuation
LowRealHigh
36.3546.4648.62
Details
Naive
Forecast
LowNextHigh
35.0237.1739.33
Details
11 Analysts
Consensus
LowTargetHigh
46.5851.1856.81
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genpact. Your research has to be compared to or analyzed against Genpact's peers to derive any actionable benefits. When done correctly, Genpact's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genpact Limited.

Genpact Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Genpact is not an exception. The market had few large corrections towards the Genpact's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genpact Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genpact within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.02
β
Beta against Dow Jones1.25
σ
Overall volatility
2.82
Ir
Information ratio 0.02

Genpact Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genpact for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genpact Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Genpact Limited generated a negative expected return over the last 90 days
Over 99.0% of the company shares are owned by institutional investors
On 23rd of December 2025 Genpact paid $ 0.17 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: Why Are Genpact Shares Soaring Today

Genpact Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genpact Stock often depends not only on the future outlook of the current and potential Genpact's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genpact's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding176.6 M
Cash And Short Term Investments1.2 B

Genpact Fundamentals Growth

Genpact Stock prices reflect investors' perceptions of the future prospects and financial health of Genpact, and Genpact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genpact Stock performance.

About Genpact Performance

By analyzing Genpact's fundamental ratios, stakeholders can gain valuable insights into Genpact's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genpact has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genpact has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 32.81  50.68 
Return On Tangible Assets 0.14  0.10 
Return On Capital Employed 0.18  0.10 
Return On Assets 0.09  0.06 
Return On Equity 0.22  0.14 

Things to note about Genpact Limited performance evaluation

Checking the ongoing alerts about Genpact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genpact Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Genpact Limited generated a negative expected return over the last 90 days
Over 99.0% of the company shares are owned by institutional investors
On 23rd of December 2025 Genpact paid $ 0.17 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: Why Are Genpact Shares Soaring Today
Evaluating Genpact's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Genpact's stock performance include:
  • Analyzing Genpact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genpact's stock is overvalued or undervalued compared to its peers.
  • Examining Genpact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Genpact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genpact's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Genpact's stock. These opinions can provide insight into Genpact's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Genpact's stock performance is not an exact science, and many factors can impact Genpact's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Genpact Stock analysis

When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges